DSFIR — DSM-Firmenich AG Share Price
0.000.00%
Last trade - 00:00- €27.93bn
- €29.99bn
- €10.63bn
- 12
- 26
- 82
- 31
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 34.6 | ||
| PEG Ratio (f) | 0.46 | ||
| EPS Growth (f) | 302.53% | ||
| Dividend Yield (f) | 2.25% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.22 | ||
| Price to Tang. Book | 1.57 | ||
| Price to Free Cashflow | 48.08 | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | n/a | n/a | 11,444 | 8,390 | 10,627 | 12,702.18 | 13,352.57 | -3.64% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | -42.68 | n/a | n/a | +33.87 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
DSM-Firmenich AG, formerly Danube AG is a Switzerland based company, which is active in nutrition, health, and beauty industry. The Company operates in four complementary businesses Perfumery & Beauty, which offer perfumery, fragrance ingredients and personal and care aroma; Taste, Texture & Health, which produces nutritional products with natural flavours and ingredients; Health, Nutrition & Care division offers customized products that contain vitamins, nutritional lipids, digestive enzymes, probiotics and cannabinoids (CBD); Animal Nutrition & Health business offers customer tailored products, solutions and services for animal farming that contain vitamins, animal proteins, carotenoids and premixes. The Company operates worldwide.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2022
- Incorporated
- May 18th, 2022
- Public Since
- April 18th, 2023
- No. of Employees
- 29,301
- Sector
- Industrial Conglomerates
- Industry
- Industrials
- Exchange
- Euronext - Amsterdam
- Shares in Issue
- 265,283,816
- Address
- Wurmisweg 576, Kaiseraugst, Kaiseraugst, 4303
- Web
- https://www.dsm-firmenich.com/corporate/home.html
- Phone
- Contact
- Sandra Segers
- Auditors
- KPMG AG
Upcoming Events for DSFIR
Q1 2024 DSM-Firmenich AG Trading Statement Call
DSM-Firmenich AG Annual Shareholders Meeting
Dividend For DSFIY.PK - 0.2674 USD
Dividend For DSFIR.AS - 2.5000 EUR
DSM-Firmenich AG Capital Markets Day
Half Year 2024 DSM-Firmenich AG Earnings Release
FAQ
What is the DSM-Firmenich AG share price?
As of Today at 19:07 UTC, shares in DSM-Firmenich AG are trading at €105.30. This share price information is delayed by 15 minutes.
How has the DSM-Firmenich AG share price performed this year?
Shares in DSM-Firmenich AG last closed at €105.30 and the price had moved by -8.89% over the past 365 days. In terms of relative price strength the DSM-Firmenich AG share price has underperformed the FTSE Global All Cap Index by -16.53% over the past year.
What are the analyst and broker recommendations for DSM-Firmenich AG?
The overall consensus recommendation for DSM-Firmenich AG is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the DSM-Firmenich AG dividend yield?
DSM-Firmenich AG does not currently pay a dividend.
Does DSM-Firmenich AG pay a dividend?
DSM-Firmenich AG does not currently pay a dividend.
When does DSM-Firmenich AG next pay dividends?
DSM-Firmenich AG does not currently pay a dividend.
How do I buy DSM-Firmenich AG shares?
To buy shares in DSM-Firmenich AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of DSM-Firmenich AG?
As of the previous close price of €105.30, shares in DSM-Firmenich AG had a market capitalisation of €27.93bn.
Where are DSM-Firmenich AG shares listed?
Here are the trading details for DSM-Firmenich AG:
- Country of listing: Netherlands
- Exchange: AEX
- Ticker Symbol: DSFIR
What kind of share is DSM-Firmenich AG?
Based on an overall assessment of its quality, value and momentum DSM-Firmenich AG is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a DSM-Firmenich AG share price forecast for 2024?
The analyst consensus target price for shares in DSM-Firmenich AG is €119.30. That is 13.3% above the last closing price of €105.30.
Analysts covering DSM-Firmenich AG currently have a consensus Earnings Per Share (EPS) forecast of €2.74 for the next financial year.
What is the trend in the DSM-Firmenich AG share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like DSM-Firmenich AG. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +12.87%.
As of the last closing price of €105.30, shares in DSM-Firmenich AG were trading +15.39% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the DSM-Firmenich AG PE Ratio?
The DSM-Firmenich AG PE ratio based on its reported earnings over the past 12 months is 34.6. The shares last closed at €105.30.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of DSM-Firmenich AG?
We do not have data on DSM-Firmenich AG's directors